Mounjaro and Parosmia - a phase IV clinical study of FDA data

Summary:

Parosmia is reported as a side effect among people who take Mounjaro (tirzepatide), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Metformin, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Parosmia when taking Mounjaro. It is created by eHealthMe based on reports of 37,587 people who have side effects when taking Mounjaro from the FDA, and is updated regularly.

What is Mounjaro?

Mounjaro has active ingredients of tirzepatide. It is often used in weight loss. eHealthMe is studying from 37,669 Mounjaro users. Check the latest studies of Mounjaro.

What is Parosmia?

Parosmia (distortion of the sense of smell, as in smelling odours that are not present) is found to be associated with 695 drugs and 766 conditions by eHealthMe. Check the latest studies of Parosmia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

37,587 people reported to have side effects when taking Mounjaro.
Among them, 17 people (0.05%) have Parosmia.

Among these 17 people:

How long have people been on Mounjaro when they have Parosmia? *

What is the gender of people who have Parosmia when taking Mounjaro? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Parosmia when taking Mounjaro? *

What are other drugs people take besides Mounjaro? *

What are other side effects people have besides Parosmia? *

Nausea (feeling of having an urge to vomit): 3 people, 17.65%
Headache (pain in head): 3 people, 17.65%
Feeling Abnormal: 2 people, 11.76%
Abdominal Pain Upper: 2 people, 11.76%
Injection Site Pain: 2 people, 11.76%
Injection Site Haemorrhage (bleeding from injection site): 2 people, 11.76%
Taste - Impaired: 1 person, 5.88%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 1 person, 5.88%
Belching (release of gas from the digestive tract): 1 person, 5.88%
Constipation: 1 person, 5.88%

What are the existing conditions these people have? *

Type 2 Diabetes: 4 people, 23.53%
Weight Decreased: 2 people, 11.76%
Glycosylated Haemoglobin Increased: 2 people, 11.76%
Abdominal Pain Upper: 2 people, 11.76%
Polycystic Ovary Disease (cysts in the ovaries that occurs when the follicle stops developing): 1 person, 5.88%
Insulin Resistance: 1 person, 5.88%
Diabetes: 1 person, 5.88%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Mounjaro and have Parosmia?

- Check whether Parosmia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mounjaro:

Mounjaro (37,669 reports)

Parosmia treatments and more:

Parosmia (8,965 reports)

Browse all side effects of Mounjaro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Parosmia:

Parosmia (695 drugs)

Browse all the conditions that are associated with Parosmia:

Parosmia (766 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tirzepatide (the active ingredients of Mounjaro) and Mounjaro (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.